Product Information
BUMETANIDE 0.5 MG TABLET is a generic product labeled by Edenbridge Pharmaceuticals LLC, priced at $0.1356 per EA under NDC 42799011901. Its NADAC has been published 542 times since Feb 10, 2016.
Strength
.5 mg/1
Manufacturer
Edenbridge Pharmaceuticals LLCNDC
42799011901
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BUMETANIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA018225On Market Since
10/15/2015
Pharmacological Classes
Price Statistics
The NADAC for BUMETANIDE 0.5 MG TABLET has been published 542 times since Feb 10, 2016, and over the history we have for it it has declined 74.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1356 per EA |
|---|---|
| All-time high | $0.7659 (Jul 12, 2017) |
| All-time low | $0.1213 (May 22, 2024) |
| 52-week high | $0.1658 |
| 52-week low | $0.1265 |
| Median price | $0.3024 |
| Average price | $0.3586 |
| Largest weekly change | +29.3% (Jun 19, 2024) |
| Weeks tracked | 542 |
| Tracking since | Feb 10, 2016 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUMETANIDE 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUMETANIDE 0.5 MG TABLET, manufactured by Edenbridge Pharmaceuticals LLC, is $0.1356 per EA (NDC 42799011901), effective Jun 24, 2026.
How has the price of BUMETANIDE 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUMETANIDE 0.5 MG TABLET has declined 74.5%. It has been tracked across 542 weekly CMS publications since Feb 10, 2016.
What are the highest and lowest recorded NADAC prices for BUMETANIDE 0.5 MG TABLET?
Since Feb 10, 2016, the NADAC for BUMETANIDE 0.5 MG TABLET has ranged from a low of $0.1213 (May 22, 2024) to a high of $0.7659 (Jul 12, 2017), with a median of $0.3024 per EA.
Are there cheaper alternatives to BUMETANIDE 0.5 MG TABLET?
7 NADAC-published products share the same active ingredient, strength, and dosage form as BUMETANIDE 0.5 MG TABLET, but none are currently priced below it.
Who manufactures BUMETANIDE 0.5 MG TABLET?
BUMETANIDE 0.5 MG TABLET (NDC 42799011901) is labeled by Edenbridge Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification